The most severe forms of type I autoimmune hepatitis are associated with genetically determined levels of TGF-β1

Johnson, 1993, Meeting report: International Autoimmune Hepatitis Group, Hepatology, 18, 998, 10.1002/hep.1840180435 Pando, 1999, Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition, Hepatology, 30, 1374, 10.1002/hep.510300611 Marcos, 1994, Two-locus involvement in the association of human leukocyte antigen with the extrahepatic manifestations of autoimmune chronic active hepatitis, Hepatology, 19, 1371, 10.1016/0270-9139(94)90230-5 Donaldson, 1991, Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors, Hepatology, 13, 701, 10.1002/hep.1840130415 Fainboim, 1994, Chronic active autoimmune hepatitis in children. Strong association with a particular HLA-DR6 (DRB1⁎1301) haplotype, Hum. Immunol., 41, 146, 10.1016/0198-8859(94)90008-6 Goldberg, 2001, Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus, Hum. Immunol., 62, 165, 10.1016/S0198-8859(00)00234-2 Czaja, 2008, HLA DRB1⁎13 as a risk factor for type 1 autoimmune hepatitis in North American patients, Dig. Dis. Sci., 53, 522, 10.1007/s10620-007-9859-4 Bayer, 1998, Transforming growth factor-beta1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity, J. Hepatol., 28, 803, 10.1016/S0168-8278(98)80230-4 Becker, 2006, TGF-beta as a T cell regulator in colitis and colon cancer, Cytokine Growth Factor Rev., 17, 97, 10.1016/j.cytogfr.2005.09.004 Munger, 1997, Latent transforming growth factor-beta: structural features and mechanisms of activation, Kidney Int., 51, 1376, 10.1038/ki.1997.188 Marek, 2005, TGF-beta1 mRNA expression in liver biopsy specimens and TGF-beta1 serum levels in patients with chronic hepatitis C before and after antiviral therapy, J. Clin. Pharm. Ther., 30, 271, 10.1111/j.1365-2710.2005.00644.x Sanderson, 1995, Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions, Proc. Natl. Acad. Sci. U. S. A., 92, 2572, 10.1073/pnas.92.7.2572 Kanzler, 1999, TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis, Am. J. Physiol., 276, G1059 Ueberham, 2003, Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis, Hepatology, 37, 1067, 10.1053/jhep.2003.50196 Ray, 2003, Transforming growth factor beta in hepatitis C virus infection: in vivo and in vitro findings, J. Gastroenterol. Hepatol., 18, 393, 10.1046/j.1440-1746.2003.02985.x Tsushima, 1999, Reduced plasma transforming growth factor-beta1 levels in patients with chronic hepatitis C after interferon-alpha therapy: association with regression of hepatic fibrosis, J. Hepatol., 30, 1, 10.1016/S0168-8278(99)80001-4 Cambien, 1996, Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study, Hypertension, 28, 881, 10.1161/01.HYP.28.5.881 Dunning, 2003, A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer, Cancer Res., 63, 2610 Yokota, 2000, Association of a T29–>C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese, Circulation, 101, 2783, 10.1161/01.CIR.101.24.2783 Suthanthiran, 2000, Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage, Proc. Natl. Acad. Sci. U. S. A., 97, 3479 Awad, 1998, Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation, Transplantation, 66, 1014, 10.1097/00007890-199810270-00009 Powell, 2000, Host genetic factors influence disease progression in chronic hepatitis C, Hepatology, 31, 828, 10.1053/he.2000.6253 Alvarez, 1999, International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis, J. Hepatol., 31, 929, 10.1016/S0168-8278(99)80297-9 Perrey, 1998, Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical report, Transpl. Immunol., 6, 193, 10.1016/S0966-3274(98)80045-2 Middleton, 2005, KIR genes, Transpl. Immunol., 14, 135, 10.1016/j.trim.2005.03.002 Bijlsma, 2002, No association between transforming growth factor beta gene polymorphism and acute allograft rejection after cardiac transplantation, Transpl. Immunol., 10, 43, 10.1016/S0966-3274(02)00021-7 Wang, 2005, Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection, World J. Gastroenterol., 11, 1929, 10.3748/wjg.v11.i13.1929 Gewaltig, 2002, Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis, Clin. Chim. Acta, 316, 83, 10.1016/S0009-8981(01)00738-0 Vidigal, 2002, Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin, J. Hepatol., 36, 271, 10.1016/S0168-8278(01)00243-4 Berndt, 2007, Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma, Carcinogenesis, 28, 1965, 10.1093/carcin/bgm155 Chernavsky, 2004, Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children, Hum. Immunol., 65, 683, 10.1016/j.humimm.2004.03.004 Paladino, 2006, Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism, J. Virol., 80, 9144, 10.1128/JVI.00339-06 Sakaguchi, 2004, Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis, Hepatogastroenterology, 51, 1780 Yamada, 1998, Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women, J. Bone Miner. Res., 13, 1569, 10.1359/jbmr.1998.13.10.1569 Guo, 2002, Role of codon 10 and codon 25 polymorphisms on TGF-beta 1 gene expression and protein synthesis in stable renal allograft recipients, Transplant. Proc., 34, 2904, 10.1016/S0041-1345(02)03483-8 Pereira, 2008, Association of TGF-beta1 codon 25 (G915C) polymorphism with hepatitis C virus infection, J. Med. Virol., 80, 58, 10.1002/jmv.21011 Ben-Ari, 2004, Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation, Cytokine, 27, 7, 10.1016/j.cyto.2004.03.009 Armendariz-Borunda, 2008, Fibrogenic polymorphisms (TGF-beta, PAI-1, AT) in Mexican patients with established liver fibrosis. Potential correlation with pirfenidone treatment, J. Investig. Med., 56, 944, 10.2310/JIM.0b013e3181891512 Yamada, 2008, The +869T/C polymorphism in the transforming growth factor-beta1 gene is associated with the severity and intractability of autoimmune thyroid disease, Clin. Exp. Immunol., 151, 379, 10.1111/j.1365-2249.2007.03575.x Lee, 2004, Transforming growth factor-beta1 polymorphisms in Korean patients with systemic sclerosis, Tissue Antigens, 63, 491, 10.1111/j.1399-0039.2004.00185.x Sugiura, 2002, Transforming growth factor beta1 gene polymorphism in rheumatoid arthritis, Ann. Rheum. Dis., 61, 826, 10.1136/ard.61.9.826 Nelson, 2000, Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders, Gastroenterology, 118, 655, 10.1016/S0016-5085(00)70134-X